An Alzheimer's Brain Bank serves as a critical resource for research into Alzheimer’s disease and dementia. It collects brain tissue from deceased individuals who had these conditions during their lifetime. This tissue is invaluable for studying the pathological changes in the brain associated with Alzheimer's, such as amyloid plaques and neurofibrillary tangles.
Researchers use the brain bank to investigate the underlying mechanisms of the disease, test new diagnostic methods, and develop potential treatments. By comparing healthy and diseased brain samples, scientists can identify biomarkers and genetic factors that contribute to Alzheimer’s progression. This research is essential for advancing our understanding of the disease and improving diagnostic accuracy and treatment efficacy.
Moreover, brain banks facilitate collaboration among scientists globally, ensuring that findings and advancements are shared to accelerate progress in Alzheimer’s research.
Title : Cerebral vascular calcium signaling in diabetic alzheimer's disease-related dementias
Yong Xiao Wang, Albany Medical College, United States
Title : Deep learning-based risk assessment of cognitive impairment using health examination data
Kaoru Sakatani, The University of Tokyo, Japan
Title : Evaluation of the neuroprotective potential of indicaxanthin from opuntia ficus indica fruit against dysmetabolism-related neurodegeneration both in vivo and in vitro
Mario Allegra, University of Palermo, Italy
Title : Cogs Club: Making a difference
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Development of imaging based biomarkers for neurovascular abnormalities in neurodegenerative diseases
Jun Hua, Johns Hopkins University School of Medicine, United States
Title : Psychosocial considerations in management of corticobasal degeneration
Esraa Askar, Forest Hills Hospital, United States